glycyl-histidyl-arginyl-proline has been researched along with sb 334867-a in 1 studies
Studies (glycyl-histidyl-arginyl-proline) | Trials (glycyl-histidyl-arginyl-proline) | Recent Studies (post-2010) (glycyl-histidyl-arginyl-proline) | Studies (sb 334867-a) | Trials (sb 334867-a) | Recent Studies (post-2010) (sb 334867-a) |
---|---|---|---|---|---|
17 | 0 | 3 | 340 | 0 | 235 |
Protein | Taxonomy | glycyl-histidyl-arginyl-proline (IC50) | sb 334867-a (IC50) |
---|---|---|---|
Orexin receptor type 1 | Homo sapiens (human) | 0.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cone, JJ; McCutcheon, JE; Roitman, MF | 1 |
1 other study(ies) available for glycyl-histidyl-arginyl-proline and sb 334867-a
Article | Year |
---|---|
Ghrelin acts as an interface between physiological state and phasic dopamine signaling.
Topics: Action Potentials; Animals; Benzoxazoles; Dopamine; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Ghrelin; Hypothalamic Area, Lateral; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neural Pathways; Neuropeptides; Nucleus Accumbens; Oligopeptides; Orexins; Rats; Rats, Sprague-Dawley; Signal Transduction; Urea; Ventral Tegmental Area; Wakefulness | 2014 |